Total Renal Care, Renal Treatment Centers Receive Antitrust Clearance On Merger; Total Renal Care and Renal Treatment Centers Each Set Record Date

Business Wire, Jan 13, 1998

TORRANCE, Calif.--(BUSINESS WIRE)--Jan. 13, 1998--Total Renal Care Holdings Inc. (NYSE:TRL) and Renal Treatment Centers Inc. (NYSE:RXT) Tuesday announced that on Jan. 5, 1998, the Federal Trade Commission and the Department of Justice granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to the pending merger of the two companies.

In addition, Total Renal Care and Renal Treatment Centers announced that each has set Jan. 20, 1998, as the record date for the determination of the TRL and RXT stockholders who will be entitled to vote on matters with respect to the merger.

On Nov. 19, 1997, the companies announced that they had entered into a definitive agreement to merge in a stock-for-stock transaction in which TRL will exchange 1.335 of its shares for each RXT share in a tax-free exchange.

Renal Treatment Centers provides dialysis treatments and ancillary services to patients suffering from chronic kidney failure, primarily in its free-standing outpatient dialysis treatment centers or in the patient's home. RXT operates a total of 180 dialysis centers in 24 states, Washington, D.C. and the Republic of Argentina. In these centers, RXT provides dialysis services for approximately 13,060 patients. RXT also provides in-patient dialysis services to more than 130 hospitals.

Total Renal Care owns and operates 203 free-standing kidney dialysis centers and home peritoneal dialysis programs in 20 states as well as Washington, D.C., Puerto Rico, Guam and Europe, serving approximately 16,200 patients. TRL also provides acute hemodialysis services to in-patients at 123 hospitals. The company operates ESRD laboratory and pharmacy facilities as well as vascular access management, transplant services and ESRD clinical research programs.

For information on Total Renal Care Holdings Inc., via facsimile at no cost, dial 800/PRO-INFO and dial company code TRL.

CONTACT: Total Renal Care Inc., Torrance

Victor M.G. Chaltiel or John E. King, 310/792-2600

or

Renal Treatment Centers Inc.

Ronald H. Rodgers Jr., 610/644-4796

or

The Financial Relations Board,

Daniel Saks/Larry Delaney, 310/442-0599 (general info)

Moira Conlon, 310/442-0599 (investor contact)

Kathy Brunson, 312/266-7800 (investor contact)